NCT00432484View on ClinicalTrials.gov

Lingzhi and Sen Miao San for the Treatment of Rheumatoid Arthritis

PHASE2CompletedINTERVENTIONAL
Enrollment

70

Participants

Timeline

Start Date

May 31, 2005

Primary Completion Date

December 31, 2006

Study Completion Date

December 31, 2006

Conditions
Rheumatoid Arthritis
Interventions
DRUG

Lingzhi and Sen Miao San

G lucidum and SMS were supplied as capsules, containing 4.0 gm of G lucidum extract, 2.4 gm of Rhizoma atractylodis (Cangzhu), 2.4 gm of Cotex phellodendri(Huangbai), and 2.4 gm of Radix achyranthes Bidentatae(Niuxi). Each patient took either 3 capsules twice daily as recommended by the TCM experts or identical-looking placebo.

Trial Locations (1)

Unknown

The Institute of Chinese Medicine, Hong Kong

All Listed Sponsors
lead

Chinese University of Hong Kong

OTHER

NCT00432484 - Lingzhi and Sen Miao San for the Treatment of Rheumatoid Arthritis | Biotech Hunter | Biotech Hunter